Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Epinephrine pre-filled syringe - DMK Pharmaceuticals

Next Previous
Search
Drug Profile

Epinephrine pre-filled syringe - DMK Pharmaceuticals

Alternative Names: Epinephrine injection PFS - DMK Pharmaceuticals; Epinephrine PFS - DMK Pharmaceuticals; Symjepi

Latest Information Update: 30 Nov 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Adamis Pharmaceuticals Corporation
  • Developer DMK Pharmaceuticals; Sandoz
  • Class Anti-infectives; Antiallergics; Antiasthmatics; Bronchodilators; Catecholamines; Ethanolamines; Skin disorder therapies; Small molecules
  • Mechanism of Action Alpha adrenergic receptor agonists; Beta adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Marketed Anaphylaxis

Most Recent Events

  • 28 Nov 2023 Epinephrine pre-filled syringe ( SYMJEPI®) is no longer licensed to US WorldMeds in USA
  • 28 Nov 2023 Epinephrine pre-filled syringe is available for licensing in USA and globally as of 28 November 2023
  • 07 Sep 2023 Adamis Pharmaceuticals Corporation is now called DMK Pharmaceuticals

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top